FDA 483 - Hoxworth Blood Center University of Cincinnati - September 08, 2025

An FDA inspection of Hoxworth Blood Center University of Cincinnati, a blood bank, identified two observations. The firm failed to consistently follow its written standard operating procedures regarding the logging of blood collection supplies and obtaining donor contact information for post-donation follow-up. These issues indicate a need for improved adherence to established quality management and donor registration protocols.